The antimicrobial peptide Cec4 has therapeutic potential against clinical carbapenem-resistant Klebsiella pneumoniae

ABSTRACT The rapid increase in carbapenem-resistant Klebsiella pneumoniae (CRKP) infections, along with the cross-resistance of CRKP to other antibiotics, has created an urgent need for novel therapeutic agents. Among the potential options for next-generation antibiotics, antimicrobial peptides (AMP...

Full description

Saved in:
Bibliographic Details
Main Authors: Lu Li, Yang Zeng, Minfang Tian, Huijun Cao, Zhilang Qiu, Guo Guo, Feng Shen, Yuping Wang, Jian Peng
Format: Article
Language:English
Published: American Society for Microbiology 2025-07-01
Series:Microbiology Spectrum
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/spectrum.02738-24
Tags: Add Tag
No Tags, Be the first to tag this record!